m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

N6-methyladenosine (m6A) has been confirmed to function critically in acute myeloid leukemia (AML) progression. Hitherto, the subtyping and prognostic predictive significance of m6A-correlated genes in AML is ...

Source: BMC Medical Genomics - August 18, 2023 Category: Genetics & Stem Cells Authors: Caizhu Fu, Ruirui Kou, Jie Meng, Duanfeng Jiang, Ruilan Zhong and Min Dong Tags: Research Source Type: research